Michael Sims
Family Medicine · Columbus, GANPI 1639170350
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 374 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,980 and has fallen 99.0% since, to $20 in 2025.
Across 374 payments — averaging $13.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$751
- AbbVie$501
- AstraZeneca$495
- Astellas Pharma US Inc$480
- Novartis$328
- Johnson & Johnson$240
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,94399%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 73 | $751 |
| AbbVie(2 entities) | 35 | $501 |
| AstraZeneca | 35 | $495 |
| Astellas Pharma US Inc | 24 | $480 |
| Novartis | 21 | $328 |
| Johnson & Johnson | 30 | $240 |
| Amarin Pharma, Inc. | 14 | $239 |
| Amgen(2 entities) | 15 | $222 |
| Eisai Inc. | 15 | $210 |
| Lilly USA, LLC | 17 | $202 |
| Pfizer | 24 | $193 |
| Boehringer Ingelheim | 9 | $161 |
| Merck | 9 | $126 |
| Esperion Therapeutics, Inc. | 7 | $122 |
| Biohaven Pharmaceuticals, Inc. | 8 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $111 |
| Sanofi-aventis U.S. LLC | 5 | $78 |
| Jazz Pharmaceuticals Inc. | 2 | $47 |
| GSK | 3 | $41 |
| Adlon Therapeutics L.p. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Aytu Biopharma, Inc. | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Vivus LLC | 2 | $21 |
| Therapeuticsmd, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Abbott | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Nalpropion Pharmaceuticals LLC | 1 | $14 |
| Dexcom, Inc. | 1 | $12 |
| Medtronic | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$4,968 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Columbus
- Jeffrey KingsleyColumbus$404K
- Bantwal BaligaColumbus$115K
- Joseph LewisColumbus$18K
- Mark SextonColumbus$18K
- Jason BermanColumbus$16K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.